Stem Cell Transplant Versus DMTs & DMTs Ease SPMS Disability Early episode artwork

EPISODE · Nov 18, 2022 · 15 MIN

Stem Cell Transplant Versus DMTs & DMTs Ease SPMS Disability Early

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how stem cell transplant is superior to Gilenya and Tysabri at preventing relapses and easing disability in RRMS patients.
He also reads another report on how early use of DMTs may lead to lower levels of disability but does not appear to slow disability progression over time.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Nov 18, 2022

Embed this episode

NOW PLAYING

Stem Cell Transplant Versus DMTs & DMTs Ease SPMS Disability Early

0:00 15:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 15 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on November 18, 2022.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!